Key facts
- This page summarizes Azrul bin Abdul Hamid Muhammad's Form 3 filing for BioNexus Gene Lab Corp (BGLC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 31 Jul 2026, 17:50.
Azrul bin Abdul Hamid Muhammad - 11 Dec 2023 Form 3 Insider Report for BioNexus Gene Lab Corp (BGLC)
- Reporting relationship
- Director
- Issuer ticker
- BGLC
- Reported as of
- 11 Dec 2023
- Net transaction value
- $0
- Reporting owner signature
- /s/ Azrul Bin Abdul Hamid Muhammad
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Azrul bin Abdul Hamid Muhammad filed Form 3 for BioNexus Gene Lab Corp (BGLC) on 31 Jul 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002141872
Primary reporting owner
Bin Abdul Hamid Muhammad Azrul
- Relationship
- Director
- Address
- NO 16 LORONG TABAN 2, LUCKY GARDEN BANGSAR, KUALA LUMPUR, MALAYSIA
- Signature
- /s/ Azrul Bin Abdul Hamid Muhammad
- Signature date
- 31 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BGLC
holding
COMMON STOCK
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 11 Dec 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.